Telehealth pioneer Hims & Hers Health (HIMS) stock is soaring, with a 12% gain in recent days and a whopping 176% in the last ...

Raising its price target on the shares to $21, reports The Fly, BofA nonetheless reiterated an "underperform" ( i.e., sell) ...

Shares of Hims & Hers Health plunged Friday after the Food & Drug Administration said a shortage of the active ingredient in ...

Shares of Hims & Hers Health ( HIMS -24.30%) are falling on Friday. The company's stock lost 23.2% as of 1 p.m. ET and lost ...

The startup is expanding its services less than one year after it started offering compounded GLP-1 weight loss drugs.

The telehealth company has been selling a copycat version of a popular obesity drug during the recent shortage.

Alright folks, Kylie Kelce is back at it with another revelation about her relationship with former Philadelphia Eagles ...

UnitedHealth declines following a report that the Justice Department has been investigating the company’s Medicare billing ...

Hims & Hers Health Inc. is expanding beyond its successful foray into providing copycat weight-loss drugs with the ...

The Israel Defense Forces (IDF) have said they are looking into reports that Hamas has handed the body of hostage Shiri Bibas ...

Hims & Hers Health acquired a peptide facility to strengthen its U.S. supply chain and meet demand for personalized ...